{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-150768","form_type":"8-K","ticker":"NRIX","cik":"0001549595","company_name":"Nurix Therapeutics, Inc.","filed_at":"2022-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.153271+00:00","generated_at":"2026-06-25T14:46:22.012548+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Clay B. Siegall resigns from Nurix Therapeutics board effective May 15, 2022","bullets":["Clay B. Siegall, Ph.D. resigned as Class II director and from Compensation Committee and Development Advisory Committee.","Resignation effective May 15, 2022; no reason provided in the filing.","No replacement named; board composition change disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-150768","json":"https://secwatch.observer/filing/0001193125-22-150768.json","markdown":"https://secwatch.observer/filing/0001193125-22-150768.md","text":"https://secwatch.observer/filing/0001193125-22-150768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549595/000119312522150768/0001193125-22-150768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549595/000119312522150768/d343186d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T14:46:22.012548+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8bc5fb1aa2","claim":"Clay B. Siegall resigned as Class II member of the Board at Nurix Therapeutics, Inc..","evidence_excerpt":"On May 15, 2022, Clay B. Siegall, Ph.D., notified the board of directors (the “Board”) of Nurix Therapeutics, Inc. of his resignation as a Class II member of the Board and as a member of the Board’s Compensation Committee and Development Advisory Committee, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549595/000119312522150768/0001193125-22-150768-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Class II member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}